Compare Amphastar Pharmaceuticals Inc (AMPH) vs Goodyear Tire & Rubber Co (GT) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Goodyear Tire & Rubber (GT) trades at $6.81, up 2.56% with a bullish technical signal despite recent earnings volatility. The stock shows attractive valuation metrics with P/E of 4.69 and P/S of 0.11, but faces profitability challenges with negative net income margin of -11.64% and ROE of -52.56%. Recent developments include the company's move to the S&P SmallCap 600 and NASA lunar tire contract, while analyst consensus targets $8.80 with mixed ratings.

The outlook remains cautious due to persistent operational headwinds and declining revenue trends, though current valuations appear discounted. Investment opportunity exists if Goodyear Forward program benefits materialize, but risks include weak tire demand, margin pressure, and high debt levels. The stock trades near 52-week lows, reflecting market skepticism about near-term turnaround prospects.